Tackling Antimicrobial Resistance in the Shadow of COVID-19

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is a challenge for ongoing efforts to combat antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 disease and drug stewardship evolves, there is likely to be a lasting impact of increased use of antimicrobial ag...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Ami Patel
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2021
Materias:	AMR DNA-encoded antibodies antimicrobial resistance bacteria gene-encoded antibodies personalized medicine Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/9c0e4ad18c7e4a4b8de72f9e8b15fcad
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9c0e4ad18c7e4a4b8de72f9e8b15fcad
record_format	dspace
spelling	oai:doaj.org-article:9c0e4ad18c7e4a4b8de72f9e8b15fcad2021-11-10T18:37:52ZTackling Antimicrobial Resistance in the Shadow of COVID-1910.1128/mBio.00473-212150-7511https://doaj.org/article/9c0e4ad18c7e4a4b8de72f9e8b15fcad2021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00473-21https://doaj.org/toc/2150-7511ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is a challenge for ongoing efforts to combat antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 disease and drug stewardship evolves, there is likely to be a lasting impact of increased use of antimicrobial agents and antibiotics, as well as a lack of consistent access to health care across many populations. Sexually transmitted infections have been underreported during the pandemic and are often caused by some of the most drug-resistant pathogens. In their recent article in mBio, Parzych et al. (E. M. Parzych, S. Gulati, B. Zheng, M. A. Bah, et al., mBio 12:e00242-21, 2021, https://doi.org/10.1128/mBio.00242-21) focus on protection against Neisseria gonorrhoeae infection via in vivo delivery of an antigonococcal DNA-encoded antibody that has been modified for increased complement activation. Nucleic acid approaches are highly adaptable and could be tremendously beneficial for personalized strategies to combat AMR pathogens.Ami PatelAmerican Society for MicrobiologyarticleAMRDNA-encoded antibodiesantimicrobial resistancebacteriagene-encoded antibodiespersonalized medicineMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	AMR DNA-encoded antibodies antimicrobial resistance bacteria gene-encoded antibodies personalized medicine Microbiology QR1-502
spellingShingle	AMR DNA-encoded antibodies antimicrobial resistance bacteria gene-encoded antibodies personalized medicine Microbiology QR1-502 Ami Patel Tackling Antimicrobial Resistance in the Shadow of COVID-19
description	ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is a challenge for ongoing efforts to combat antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 disease and drug stewardship evolves, there is likely to be a lasting impact of increased use of antimicrobial agents and antibiotics, as well as a lack of consistent access to health care across many populations. Sexually transmitted infections have been underreported during the pandemic and are often caused by some of the most drug-resistant pathogens. In their recent article in mBio, Parzych et al. (E. M. Parzych, S. Gulati, B. Zheng, M. A. Bah, et al., mBio 12:e00242-21, 2021, https://doi.org/10.1128/mBio.00242-21) focus on protection against Neisseria gonorrhoeae infection via in vivo delivery of an antigonococcal DNA-encoded antibody that has been modified for increased complement activation. Nucleic acid approaches are highly adaptable and could be tremendously beneficial for personalized strategies to combat AMR pathogens.
format	article
author	Ami Patel
author_facet	Ami Patel
author_sort	Ami Patel
title	Tackling Antimicrobial Resistance in the Shadow of COVID-19
title_short	Tackling Antimicrobial Resistance in the Shadow of COVID-19
title_full	Tackling Antimicrobial Resistance in the Shadow of COVID-19
title_fullStr	Tackling Antimicrobial Resistance in the Shadow of COVID-19
title_full_unstemmed	Tackling Antimicrobial Resistance in the Shadow of COVID-19
title_sort	tackling antimicrobial resistance in the shadow of covid-19
publisher	American Society for Microbiology
publishDate	2021
url	https://doaj.org/article/9c0e4ad18c7e4a4b8de72f9e8b15fcad
work_keys_str_mv	AT amipatel tacklingantimicrobialresistanceintheshadowofcovid19
_version_	1718439801217089536

Tackling Antimicrobial Resistance in the Shadow of COVID-19

Ejemplares similares